Skip to main content
. 2010 Nov 3;9:37. doi: 10.1186/1744-859X-9-37

Figure 1.

Figure 1

Effects of acute treatments with etizolam and ethyl loflazepate on P300. *P < 0.05, **P < 0.01, ***P < 0.001 compared to pretreatment (repeated analysis of variance (ANOVA)). (a) Trend for changes without significance. *P < 0.05, **P < 0.01 compared to ethyl loflazepate with low dose (1 mg) (ANOVA followed by Fisher's protected least significant difference test).

HHS Vulnerability Disclosure